Alison Sundem
Overview
Explore the profile of Alison Sundem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lintecum K, Thumsi A, Dunn K, Druschel L, Chimene S, Prieto D, et al.
bioRxiv
. 2024 Dec;
PMID: 39677609
Teaser: In this study, a vaccine formulation was generated to develop central nervous specific immunosuppressive responses for TBI.
2.
Inamdar S, Suresh A, Mangal J, Ng N, Sundem A, Wu C, et al.
Nat Commun
. 2023 Sep;
14(1):5333.
PMID: 37660049
Inhibition of glycolysis in immune cells and cancer cells diminishes their activity, and thus combining immunotherapies with glycolytic inhibitors is challenging. Herein, a strategy is presented where glycolysis is inhibited...
3.
Inamdar S, Suresh A, Mangal J, Ng N, Sundem A, Shokrollahzadeh Behbahani H, et al.
Biomaterials
. 2023 Aug;
301:122292.
PMID: 37643489
Succinate is an important metabolite that modulates metabolism of immune cells and cancer cells in the tumor microenvironment (TME). Herein, we report that polyethylene succinate (PES) microparticles (MPs) biomaterial mediated...
4.
Inamdar S, Suresh A, Mangal J, Ng N, Sundem A, Shokrollahzadeh Behbahani H, et al.
J Control Release
. 2023 May;
358:541-554.
PMID: 37182805
Boosting the metabolism of immune cells while restricting cancer cell metabolism is challenging. Herein, we report that using biomaterials for the controlled delivery of succinate metabolite to phagocytic immune cells...